Catalyst Wire Dossier Catalyst Wire Dossier

TAG72-CAR T Cells

· City of Hope Medical Center
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAG72-CAR T Cells, covering 2025-07-01 to 2025-07-01. Get the full timeline:

Most recent: Clinical Trial Update: Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer [Phase 1]

See pricing